Literature DB >> 24105047

Peroxiredoxin 3 is resistant to oxidation-induced apoptosis of Hep-3b cells.

Y-G Wang1, L Li, C-H Liu, S Hong, M-J Zhang.   

Abstract

OBJECTIVE: Although peroxiredoxin 3 (PRX3) was reported to be overexpressed in liver cancer, the precise function of PRX3 in the development and/or progression of liver cancer remained to be obscure. The present study was conducted to investigate the response of PRX3 to oxidative stress in hepatocellular carcinoma (HCC) cells.
METHODS: After successful knockdown of PRX3 expression by small interfering RNA, we treated HCC cell lines Hep-3b and Hep-G2 with gradient concentrations of H2O2 and detected cell proliferation, apoptosis, and the level of reactive oxygen species (ROS) in the cells.
RESULTS: After low-dose (5-20 μmol/l) H2O2 treatment, the ROS level was significantly higher in PRX3-knockdown Hep-3b cells than in controls. In addition, PRX3 down-regulation resulted in decreased proliferation, increased apoptosis, and increased caspase 3 activity of Hep-3b cells. We did not notice significant difference between PrxIII knockdown and control Hep-G2 cells in ROS level, cell viability or apoptosis.
CONCLUSION: Our results suggest that PRX3 is an indispensable ROS scavenger that protects tumor cells against oxidative damage and subsequent apoptosis, which provides a clue that PRX3 may be involved in the chemotherapeutic resistance of liver cancer. The underlying mechanism for PRX3 function needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24105047     DOI: 10.1007/s12094-013-1117-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  29 in total

1.  Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung.

Authors:  Joo Hun Park; Young Sun Kim; Hye Lim Lee; Jin Young Shim; Keu Sung Lee; Yoon Jung Oh; Seung Soo Shin; Young Hwa Choi; Kwang Joo Park; Rae Woong Park; Sung Chul Hwang
Journal:  Respirology       Date:  2006-05       Impact factor: 6.424

Review 2.  Therapeutic options for intermediate-advanced hepatocellular carcinoma.

Authors:  Zong-Ming Zhang; Jin-Xing Guo; Zi-Chao Zhang; Nan Jiang; Zhen-Ya Zhang; Li-Jie Pan
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

3.  Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach.

Authors:  Bingbing Qiao; Jiajia Wang; Jianfei Xie; Ying Niu; Shaojun Ye; Qiquan Wan; Qifa Ye
Journal:  Int J Mol Med       Date:  2012-02-15       Impact factor: 4.101

4.  Increased expression of peroxiredoxin II confers resistance to cisplatin.

Authors:  Y M Chung; Y D Yoo; J K Park; Y T Kim; H J Kim
Journal:  Anticancer Res       Date:  2001 Mar-Apr       Impact factor: 2.480

5.  Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo.

Authors:  Jérôme Alexandre; Frédéric Batteux; Carole Nicco; Christiane Chéreau; Alexis Laurent; Loïc Guillevin; Bernard Weill; François Goldwasser
Journal:  Int J Cancer       Date:  2006-07-01       Impact factor: 7.396

6.  Peroxiredoxins in colorectal neoplasms.

Authors:  X Y Wu; Z X Fu; X H Wang
Journal:  Histol Histopathol       Date:  2010-10       Impact factor: 2.303

7.  Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas.

Authors:  Joon Hyuk Choi; Tae Nyeun Kim; Seongyong Kim; Suk-Hwan Baek; Jung Hye Kim; Seung Rock Lee; Jae-Ryong Kim
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

8.  Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China.

Authors:  Peipei Song; Xiaobin Feng; Keming Zhang; Tianqiang Song; Kuansheng Ma; Norihiro Kokudo; Jiahong Dong; Linong Yao; Wei Tang
Journal:  Biosci Trends       Date:  2013-02       Impact factor: 2.400

9.  Crucial role of peroxiredoxin III in placental antioxidant defense of mice.

Authors:  Lianqin Li; Wataru Shoji; Hiroaki Oshima; Masuo Obinata; Manabu Fukumoto; Naoko Kanno
Journal:  FEBS Lett       Date:  2008-06-09       Impact factor: 4.124

10.  Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress.

Authors:  H C Whitaker; D Patel; W J Howat; A Y Warren; J D Kay; T Sangan; J C Marioni; J Mitchell; S Aldridge; H J Luxton; C Massie; A G Lynch; D E Neal
Journal:  Br J Cancer       Date:  2013-07-23       Impact factor: 7.640

View more
  9 in total

Review 1.  The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells.

Authors:  Lianqin Li; Ai-Qun Yu
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-21       Impact factor: 4.553

Review 2.  Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer.

Authors:  Suet-Hui Ow; Pei-Jou Chua; Boon-Huat Bay
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

3.  microRNA-383 mediates high glucose-induced oxidative stress and apoptosis in retinal pigment epithelial cells by repressing peroxiredoxin 3.

Authors:  Yanyun Jiang; Yanzhi Sang; Qinghua Qiu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

4.  Methylthioadenosine (MTA) Regulates Liver Cells Proteome and Methylproteome: Implications in Liver Biology and Disease.

Authors:  Emilie Bigaud; Fernando J Corrales
Journal:  Mol Cell Proteomics       Date:  2016-01-27       Impact factor: 5.911

5.  Metallothionein-I/II Knockout Mice Aggravate Mitochondrial Superoxide Production and Peroxiredoxin 3 Expression in Thyroid after Excessive Iodide Exposure.

Authors:  Na Zhang; Lingyan Wang; Qi Duan; Laixiang Lin; Mohamed Ahmed; Tingting Wang; Xiaomei Yao
Journal:  Oxid Med Cell Longev       Date:  2015-05-25       Impact factor: 6.543

Review 6.  Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy.

Authors:  Barbara Marengo; Mariapaola Nitti; Anna Lisa Furfaro; Renata Colla; Chiara De Ciucis; Umberto Maria Marinari; Maria Adelaide Pronzato; Nicola Traverso; Cinzia Domenicotti
Journal:  Oxid Med Cell Longev       Date:  2016-06-21       Impact factor: 6.543

Review 7.  The Role of MicroRNAs in Mitochondria-Mediated Eye Diseases.

Authors:  Sabrina Carrella; Filomena Massa; Alessia Indrieri
Journal:  Front Cell Dev Biol       Date:  2021-06-18

8.  Transforming Growth Factor-β Drives the Transendothelial Migration of Hepatocellular Carcinoma Cells.

Authors:  Petra Koudelkova; Victor Costina; Gerhard Weber; Steven Dooley; Peter Findeisen; Peter Winter; Rahul Agarwal; Karin Schlangen; Wolfgang Mikulits
Journal:  Int J Mol Sci       Date:  2017-10-10       Impact factor: 5.923

Review 9.  Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases.

Authors:  Mi Hee Park; MiRan Jo; Yu Ri Kim; Chong-Kil Lee; Jin Tae Hong
Journal:  Pharmacol Ther       Date:  2016-04-26       Impact factor: 12.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.